Literature DB >> 15016728

Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor.

Xander H T Wehrens1, Stephan E Lehnart, Steven R Reiken, Andrew R Marks.   

Abstract

The cardiac ryanodine receptor (RyR2)/calcium release channel on the sarcoplasmic reticulum is required for muscle excitation-contraction coupling. Using site-directed mutagenesis, we identified the specific Ca2+/calmodulin-dependent protein kinase II (CaMKII) phosphorylation site on recombinant RyR2, distinct from the site for protein kinase A (PKA) that mediates the "fight-or-flight" stress response. CaMKII phosphorylation increased RyR2 Ca2+ sensitivity and open probability. CaMKII was activated at increased heart rates, which may contribute to enhanced Ca2+-induced Ca2+ release. Moreover, rate-dependent CaMKII phosphorylation of RyR2 was defective in heart failure. CaMKII-mediated phosphorylation of RyR2 may contribute to the enhanced contractility observed at higher heart rates. The full text of this article is available online at http://circres.ahajournals.org.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016728     DOI: 10.1161/01.RES.0000125626.33738.E2

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  276 in total

Review 1.  CaMKII in myocardial hypertrophy and heart failure.

Authors:  Mark E Anderson; Joan Heller Brown; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2011-01-27       Impact factor: 5.000

2.  Ca²+-dependent phosphorylation of RyR2 can uncouple channel gating from direct cytosolic Ca²+ regulation.

Authors:  Simon Carter; Samantha J Pitt; John Colyer; Rebecca Sitsapesan
Journal:  J Membr Biol       Date:  2011-01-28       Impact factor: 1.843

Review 3.  Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Authors:  Luigi Venetucci; Marco Denegri; Carlo Napolitano; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

4.  How does CaMKIIdelta phosphorylation of the cardiac ryanodine receptor contribute to inotropy?

Authors:  David A Eisner; Christopher H George; Godfrey L Smith; Andrew W Trafford; Luigi A Venetucci
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-21       Impact factor: 11.205

5.  Synergy between CaMKII substrates and β-adrenergic signaling in regulation of cardiac myocyte Ca(2+) handling.

Authors:  Anthony R Soltis; Jeffrey J Saucerman
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

6.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.

Authors:  Sung-Jun Park; Faiyaz Ahmad; Andrew Philp; Keith Baar; Tishan Williams; Haibin Luo; Hengming Ke; Holger Rehmann; Ronald Taussig; Alexandra L Brown; Myung K Kim; Michael A Beaven; Alex B Burgin; Vincent Manganiello; Jay H Chung
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

7.  Modulation of cardiac sarcoplasmic reticulum calcium release by aenosine: a protein kinase C- dependent pathway.

Authors:  Sandra Ghelardoni; Sabina Frascarelli; Vittoria Carnicelli; Simonetta Ronca-Testoni; Riccardo Zucchi
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

Review 8.  New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII).

Authors:  Adam G Rokita; Mark E Anderson
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

9.  Redox modification of ryanodine receptors by mitochondria-derived reactive oxygen species contributes to aberrant Ca2+ handling in ageing rabbit hearts.

Authors:  Leroy L Cooper; Weiyan Li; Yichun Lu; Jason Centracchio; Radmila Terentyeva; Gideon Koren; Dmitry Terentyev
Journal:  J Physiol       Date:  2013-09-16       Impact factor: 5.182

10.  Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling.

Authors:  Jiali Nie; Quanlu Duan; Mengying He; Xianqing Li; Bei Wang; Chi Zhou; Lujin Wu; Zheng Wen; Chen Chen; Dao Wu Wang; Katherina M Alsina; Xander H T Wehrens; Dao Wen Wang; Li Ni
Journal:  J Cell Physiol       Date:  2018-11-29       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.